The Chemours Company
CC
$14.62
-$0.3625-2.42%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 18.06% | -1.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 18.06% | -1.87% | |||
| Cost of Revenue | 18.11% | 0.98% | |||
| Gross Profit | 17.80% | -13.55% | |||
| SG&A Expenses | 47.11% | -39.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.55% | -4.90% | |||
| Operating Income | -18.18% | 83.33% | |||
| Income Before Tax | -- | -100.00% | |||
| Income Tax Expenses | 2,875.00% | -76.47% | |||
| Earnings from Continuing Operations | -9,400.00% | 50.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9,425.00% | 50.00% | |||
| EBIT | -18.18% | 83.33% | |||
| EBITDA | -7.88% | 30.95% | |||
| EPS Basic | -9,398.13% | 50.00% | |||
| Normalized Basic EPS | -61.32% | 499.40% | |||
| EPS Diluted | -8,366.67% | 49.75% | |||
| Normalized Diluted EPS | -61.32% | 499.40% | |||
| Average Basic Shares Outstanding | 0.21% | 0.06% | |||
| Average Diluted Shares Outstanding | 0.21% | 0.06% | |||
| Dividend Per Share | -65.00% | 0.00% | |||
| Payout Ratio | 1.00% | -1.06% | |||